DARIA is the Drug and Alcohol Research and Innovation Active-Learning Network.
DARIA is an online monthly seminar program delivered by the National Centre for Clinical Research on Emerging Drugs (NCCRED) in partnership with St Vincent’s Hospital Sydney.
The aim of the series is to promote innovative practice and share learnings and new ideas among clinicians and clinical researchers working in the field of methamphetamine, emerging drugs, and other areas of alcohol and drug health.
Cannabis use among people with opioid use disorder – 20 Nov 2023
Presented by Jack Wilson and Laila Parvaresh.
Overcoming barriers to women accessing treatment for methamphetamine use – 18 Oct 2023
Presented by Anna McVinish, Suzie Hudson and Prof Nadine Ezard.
Responding to emerging drugs of concern: nitazenes – 25 September 2023
Presented by A/Prof. Darren Roberts, A/Prof. Jennifer Schumann, and Mitch Lamb. Chaired by Prof. Nadine Ezard.
Sleep, circadian rhythms and substance use – 18 September 2023
Presented by Dr Rowan Ogeil, Dr Damon Ashworth and Liam Acheson.
Psychosocial interventions for families affected by another’s alcohol or other drug use – 21 August 2023
Presented by Clare Rushton, Psychologist (Clinical registrar) and PhD Candidate at the University of Wollongong.
Long term patterns of heroin use and mental health, 20 years on – 17 July 2023
Presented by Dr Christina Marel and Dr Chris Tremonti.
Dr Christina Marel is a Senior Research Fellow and Program Lead at the Matilda Centre for Research in Mental Health and Substance Use at the University of Sydney.
Dr Chris Tremonti is an addiction specialist and clinical pharmacologist.
Using health data to understand people who use Amphetamine – 19 June 2023
Presented by Emma Black, Professor Adrian Dunlop and Dr Llewellyn Mills.
Discontinuation of OTP – 15 May 2023
Presented by Dr Thomas Lu
Dr Thomas Lu is a GP in the Sutherland Shire, and also an addiction medicine trainee at the Langton Centre.
Strengthening first-line telehealth for people who use Methamphetamine and Emerging Drugs – 17 April 2023
Presented by Dr Krista Siefried & Alana Story
Dr Krista Siefried is the Clinical Research Lead and Deputy Director at NCCRED.
Alana Story is the senior clinician for the Alcohol and Drug Contact Centre at St Vincent’s Hospital.
Poppy seed tea and thebaine poisoning – 12 December 2022
Presented by Dr Darren Roberts
Dr Darren Roberts is a physician subspecialising in clinical pharmacology, addiction medicine and nephrology. He is medical director of the NSW Poisons Information Centre, staff specialist in Drug Health at Sydney Local Health District, and Conjoint Associate Professor at University of New South Wales.
Prompt Response Network – 5 December 2022
Presented by Dr Penny Hill
Dr Penny Hill is the Prompt Response Network Lead and Emerging Drugs Research Fellow at NCCRED.
Drug testing in addiction medicine – 28 November 2022
Presented by Dr Chris Tremonti
Dr Chris Tremonti is an Addiction Physician and Clinical Pharmacologist working as a Staff specialist at St Vincent’s Hospital.
Cannabis hyperemesis management- 21 November 2022
Presented by Dr Jay Ramanathan & Dr Una Nic Ionmhain
Dr Nic Ionmhain is an Emergency Physician based in Liverpool hospital in NSW. With Dr Ramanathan, she is a member of the Liverpool Hospital Toxicology service and is a current NSW Poisons Information Centre Fellow.
Situational Counselling for Domestic Violence Disclosure – AOD Context – 14 November 2022
Presented by Adele Sheridan Magro
Manager of the Domestic & Family Violence Service at St Vincent’s Hospital Sydney
Performance & Image Enhancement: what should health services be doing?- 31 October 2022
Presented by Dr James Blogg
Senior Staff Specialist, Drug Health Services at Sydney LHD
Case Management and Care Planning: Applying the NSW Health Clinical Care Standards in the AOD sector – 17 October 2022
Presented by Dr Suzie Hudson
Clinical Advisor to the Centre for Alcohol and Other Drugs at the NSW Ministry of Health
The Alcohol and drug Cognitive Enhancement (ACE) Program – 26 September 2022
Presented by Dr Jamie Berry
Clinical Neuropsychologist, Director of group private practice, Advanced Neuropsychological Treatment Services (ANTS)
Clinical Associate Professor, Faculty of Medicine, Health and Human Science at Macquarie University
Novel Opioids – Case Series on the use of Kamini – 19 September 2022
Presented by Dr Thileepan Naren
GP & Addiction Medicine Advanced Trainee, Western Health Melbourne. Co-host of Cracking Addiction podcast
Motivational Interviewing & Stages of Change – 12 September 2022
Presented by Dr David St Quintin
Clinical Psychologist, Illawarra Shoalhaven Local Health District
Open-label trial of oral lisdexamfetamine for the treatment of acute methamphetamine withdrawal (the OLAM study) – 5 September 2022
Presented by Liam Acheson
PhD Candidate, NDARC, The University of New South Wales (UNSW) and Research Officer, St Vincent’s Hospital Sydney
Injectable Hydromorphone – Feasibility of Opioid Injecting Trial (FOPiT) – 22 August 2022
Presented by Dr Craig Rodgers B Med MPH FRACGP FAChAM
Senior Staff Specialist, Alcohol and Drug Service, St Vincent’s Hospital Sydney
Use of dexmedetomadine in alcohol withdrawal delirium – 15 August 2022
Presented by Dr Chris Tremonti FAChAM FRACP
Staff Specialist, Alcohol and Drug Service, St Vincent’s Hospital Sydney
Alcohol use in Aboriginal and Torres Strait Islander Communities – Recent research and evidence – 1 August 2022
Kate Conigrave – Addiction Medicine Specialist and Public Health Physician, Royal Prince Alfred Hospital, Co-Director Centre of Research Excellence in Indigenous Health and Alcohol
Teagan Weatherall – Kamilaroi and Anaiwan woman, PhD candidate University of Sydney, Research assistant CRE in Indigenous Health and Alcohol
Methamphetamine use during pregnancy – 25 July 2022
Presented by Dr Angela O’Connor
Nurse and Midwife, Clinical Lead, North Metro Health Service
Motivational Interviewing and Trauma in the AOD space – 18 July 2022
Presented by Dr David St Quintin
Clinical Psychologist, Illawarra Shoalhaven Local Health District
Staff Specialist, Alcohol and Drug Service, St Vincent’s Hospital Sydney, Clean Slate Clinic
ChemSex and harm reduction for gay and bisexual men in Australia – 27 June 2022
Presented by A/Prof Adam Bourne
Australian Research Centre in Sex, Health & Society, LaTrobe University
Capacity and Substance Use Disorder – Alcohol – 20 June 2022
Presented by Dr Chris Ryan
Clinical Associate Professor, University of Sydney
Director of Consultation-Liaison Psychiatry, Westmead Hospital Clinical School
GHB Experiences and cultures of practices amongst LGBTQ people – 6 June 2022
Presented by Mr Jack Freestone
Alcohol and Other Drugs Research and Development, ACON
PhD Candidate, NCCRED & Kirby Institute, UNSW
Nitrous oxide-induced myeloneuropathy – 30 May 2022
Presented by Dr Grace Swart
Neurologist, Brain and Mind Centre, University of Sydney
Psychedelics for the treatment of substance use disorders – 16 May 2022
Presented by Dr Jonathan Brett
Associate Professor, The University of New South Wales (UNSW)
Senior staff specialist, Clinical Pharmacology, Toxicology and Addiction Medicine, St Vincent’s Hospital Sydney
The role of electronic cigarettes to quit smoking – 9 May 2022
Presented by Prof Hayden McRobbie
Professor, National Drug and Alcohol Research Centre, UNSW, Sydney Australia
Consultant in Lifestyle Medicine, Lakes District Health Board, Rotorua, New Zealand
Methadone Buprenorphone Transfers – 11 April 2022
Presented by Dr Chris Tremonti FAChAM FRACP
Staff Specialist, Alcohol and Drug Service, St Vincent’s Hospital Sydney
Pharmacotherapy for Methamphetamine Use Disorder – 4 April 2022
Presented by Dr Krista Siefried
Clinical Research Lead and Deputy Director, National Centre for Clinical Research on Emerging Drugs (NCCRED)
Senior Lecturer, The University of New South Wales (UNSW)
Senior Research Fellow, Alcohol and Drug Service, St Vincent’s Hospital Sydney
Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder A Randomized Clinical Trial JAMA Psychiatry – 24 October 2022
Presented by Dr Roman Pillay
Physician trainee at St Vincent’s Hospital in Sydney
Opioid Vs opioid-free analgesia after surgical discharge – 29 August 2022
Presented by Dr Eleanor McLaren MBChB BSc
Emergency Medicine Registrar, St Vincent’s Hospital Sydney
Clinical management of cannabis withdrawal – 8 August 2022
Presented Dr Georgie Mair
GP Registrar, Alcohol and Drug Service, St Vincent’s Hospital Sydney
Baclofen to prevent relapse in GHB dependent patients – 11 July 2022
Presented by Dr Ryan Cocker
Psychiatry (Addictions) Advanced Trainee, Alcohol and Drug Service, St Vincent’s Hospital Sydney
Pharmacotherapies for Methamphetamine Withdrawal – 23 May 2022
Presented by Mr Liam Acheson
PhD Candidate, NDARC, The University of New South Wales (UNSW)
Research Officer, St Vincent’s Hospital Sydney
Bupropion and naltrexone for methamphetamine use disorder – 2 May 2022
Presented by Dr Jeku Jacob
Paper discussed: Trivedi, M. H., Walker, R., Ling, W., Dela Cruz, A., Sharma, G., Carmody, T., Ghitza, U. E., Wahle, A., Kim, M., Shores-Wilson, K., Sparenborg, S., Coffin, P., Schmitz, J., Wiest, K., Bart, G., Sonne, S. C., Wakhlu, S., Rush, A. J., Nunes, E. V., & Shoptaw, S. (2021). Bupropion and Naltrexone in Methamphetamine Use Disorder. New England Journal of Medicine, 384(2), 140–153. https://doi.org/10.1056/NEJMoa2020214
National Centre for Clinical Research on Emerging Drugs
We would like to acknowledge the Traditional Owners of this country and pay our respects to Elders past, present and emerging.
